The outbreak strain has been identified as a swine-origin influenza virus that resulted from a reassortment of two previously circulating strains: a “triple-reassortant” swine influenza that has been circulating in
According to Dr. Adrian Gibbs, the prominent virologists who worked with the Swiss drug maker Roche to develop the anti-influenza drug oseltamivir (Tamiflu), the Swine Flu is Man-Made. In a Bloomberg News interview from May 13, 2009, Dr. Adrian Gibbs described the vast improbability of a virus self-assembling out of DNA sequences from four distinct species, without adequate evolutionary time to do so.